WHO ICTRP trial
A Study to Evaluate the Efficacy and Safety of BMN 111 in Children With…
JPRN-jRCT2080224106 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2080224106 |
|---|---|
| Public title | A Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia |
| Scientific title | A Phase 3 Randomized, Double-Blind,Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BMN 111 in Children with Achondroplasia |
| Primary sponsor | BioMarin Pharmaceutical Inc.(ICCC:EPS International Holdings Co. Ltd.) |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | Japan;North America;Europe;Oceania |
| Conditions | Achondroplasia |
| Interventions | investigational material(s) Generic name etc : modified recombinant human C-type natriuretic peptide INN of investigational material : Vosoritide Therapeutic category code : 249 Other hormone preparations (including antihormone… |
| Registration date | Oct 23, 2018 |
| Target size | 6 |
| Secondary IDs | NCT03197766;JapicCTI-184167 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: